Trial Summary
What is the purpose of this trial?The aim of the ROCQ programme is to improve the use of evidence based osteoporosis diagnostic and treatment strategies for women 50 years and over who have suffered a fragility fracture. This objective will be achieved by concentrating on a realistic evaluation of the present diagnosis and treatment rate of osteoporosis following a fragility fracture and comparing it to an optimal situation (care gap) and proposing interventions that promote new approaches to treating osteoporosis by health professionals as well as providing targeted interventions for the patient. The efficacy of these interventions will be evaluated using a randomized control design.
Eligibility Criteria
This trial is for women aged 50 or older who have had a fragility fracture, can understand the study information and consent form, agree to participate voluntarily, and are able to complete questionnaires over the phone. It excludes those already in a clinical trial for osteoporosis medication, unable to grasp the programme's purpose, or with fractures due to severe trauma or disease.Inclusion Criteria
I can participate in phone interviews.
Must voluntarily accept to participate in this programme and sign the consent form
I am a woman aged 50 or older.
+3 more
Exclusion Criteria
I have had a fracture due to my cancer.
I am in a clinical trial for osteoporosis medication.
Unable to understand the purpose of the programme
+1 more
Participant Groups
The ROCQ programme aims to improve osteoporosis care by evaluating current diagnosis and treatment rates after fragility fractures against an ideal scenario. Interventions include educational materials and videos for patients and healthcare professionals. The effectiveness of these interventions will be measured using a randomized control design.
2Treatment groups
Experimental Treatment
Group I: VideoExperimental Treatment1 Intervention
A 15-minute educational video on osteoporosis as well as written documentation on osteoporosis for the participant and the physician.
Group II: DocumentationExperimental Treatment1 Intervention
Written educational material on osteoporosis for the participant and the physician.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
CHUdeQuebec, CHULQuebec, Canada
Loading ...
Who Is Running the Clinical Trial?
CHU de Quebec-Universite LavalLead Sponsor
Merck Frosst Canada Ltd.Industry Sponsor
AmgenIndustry Sponsor
Eli Lilly and CompanyIndustry Sponsor
SanofiIndustry Sponsor
Procter and GambleIndustry Sponsor
NovartisIndustry Sponsor